Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd)"
Count: 20
Selected: 0
NCT05605197U87 CART in Treatment of Advanced Solid Tumor
NCT06367114Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)
NCT05768529Clinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05732948PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
NCT05381662CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment
NCT04825496Clinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT03896854CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
NCT03614858CD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
NCT03275493CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
NCT03064269CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia
NCT05315778Anti-BCMA CAR T-Cell Therapy for R/R ITP
NCT04923789A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma
NCT04539444A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma
NCT03919240CAR-T Cell Therapy Targeting to CD19 for R/R ALL
NCT03468153Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma
NCT03267173Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer.
NCT03196830CAR-T for R/R B-NHL
NCT06381830Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
NCT04846439Sequential Infusion of CD19 and BCMA CAR-T Cells to Improve PTR in Patients With AL
NCT04287660Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients